Aleksandra Maleska Maceski

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis

Stéphanie Meier, Eline A.J. Willemse, Sabine Schaedelin et al. · JAMA Neurology · 2023 · 230 citations · Full text

Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

Juan Fortea, María Carmona‐Iragui, Bessy Benejam et al. · The Lancet Neurology · 2018 · 205 citations

Down Syndrome, Alzheimer's Disease, Csf Biomarkers +11

Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity

Xavier Ayrignac, Emmanuelle Le Bars, Claire Duflos et al. · Scientific Reports · 2020 · 130 citations · Full text

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale

Sylvain Lehmann, Constance Delaby, Guilaine Boursier et al. · Frontiers in Aging Neuroscience · 2018 · 84 citations · Full text

GnRH replacement rescues cognition in Down syndrome

María Manfredi-Lozano, Valérie Leysen, Michela Adamo et al. · Science · 2022 · 81 citations · Full text

Neuropsychology, Brain Function, Neurological Disorder +17